Labopharm to host conference call Friday, November 6, 2009 at 10:00 a.m. (ET)
- Management to discuss third quarter financial results -
LAVAL, QC,
To access the conference call by telephone, dial 416-644-3422 or 1-877-974-0448. Please connect approximately 15 minutes prior to the beginning of the call to ensure participation. The conference call will be archived for replay until
A live audio webcast of the conference call will be available at www.labopharm.com. Please connect at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be required to join the webcast. The webcast will be archived at the above web site for 30 days.
About Labopharm Inc.
Labopharm is an emerging leader in optimizing the performance of existing small molecule drugs using its proprietary controlled-release technologies. The Company's lead product, a unique once-daily formulation of tramadol, is now available in 17 countries around the world, including the U.S.,
For further information: At Labopharm: Mark D'Souza, Senior Vice-President and Chief Financial Officer, Tel: (450) 686-0207; At The Equicom Group: Jason Hogan, Media and Investor Relations, Tel: (416) 815-0700, [email protected]; French: Joe Racanelli, Tel: (514) 844-7997, [email protected]
Share this article